key: cord-0898022-kzvdmj2n
authors: Chioh, F. W.; Fong, S.-W.; Young, B.; Wu, K.-X.; Siau, A.; Krishnan, S.; Chan, Y.-H.; Teo, L. L.; Gao, F.; Tan, R. S.; Zhong, L.; Koh, A. S.; Tan, S. Y.; Tambyah, P. A.; Renia, L.; Ng, L. F. P.; Lye, D. C. B.; Cheung, C.
title: Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
date: 2020-11-18
journal: nan
DOI: 10.1101/2020.11.16.20232835
sha: 8b36de96438f91cb3b9ce94fe3d1b6c94d0359a5
doc_id: 898022
cord_uid: kzvdmj2n

The rapid rise of coronavirus disease 2019 patients who suffer from vascular events after their initial recovery is expected to lead to a worldwide shift in disease burden. We aim to investigate the impact of COVID-19 on the pathophysiological state of blood vessels in convalescent patients. Here, convalescent COVID-19 patients with or without preexisting conditions (i.e. hypertension, diabetes, hyperlipidemia) were compared to non-COVID-19 patients with matched cardiovascular risk factors or healthy participants. Convalescent patients had elevated circulating endothelial cells (CECs), and those with underlying cardiovascular risk had more pronounced endothelial activation hallmarks (ICAM1, P-selectin or CX3CL1) expressed by CECs. Multiplex microbead-based immunoassays revealed some levels of cytokine production sustained from acute infection to recovery phase. Several proinflammatory and activated T lymphocyte-associated cytokines correlated positively with CEC measures, implicating cytokine-driven endothelial dysfunction. Finally, the activation markers detected on CECs mapped to the counter receptors (i.e. ITGAL, SELPLG, and CX3CR1) found primarily on CD8+ T cells and natural killer cells, suggesting that activated endothelial cells could be targeted by cytotoxic effector cells. Clinical trials in preventive therapy for post-COVID-19 vascular complications may be needed.

constitute an ideal cell-based biomarker as it is indicative of in situ endothelial pathophysiology (Farinacci, 99 Krahn et al., 2019, Hill, Zalos et al., 2003) . Although CECs are a rare population in peripheral blood, they 100 reflect endothelial dysfunction from a variety of vascular disorders including myocardial infarction, acute 101 ischemic stroke, atherosclerosis and vasculitis (Nadar, Lip et al., 2005 , Schmidt, Manca et al., 2015 . In 102 COVID-19, there are conflicting reports as to the frequency of CEC counts compared with healthy controls 103 (Mancuso, Gidaro et al., 2020 , Nizzoli, Merati et al., 2020 . This discrepancy may reflect disease severity 104 as COVID-19 patients admitted to the intensive care unit (ICU) have a higher CEC count, suggesting more 105 pronounced endothelial injury in severe COVID-19 (Guervilly, Burtey et al., 2020) . Interestingly, among 106 non-ICU patients, those with chronic kidney disease had significantly higher CEC counts, implying that 107 patients with pre-existing conditions may be more susceptible to vascular damage (Guervilly et al., 2020) . 108

This study aims to understand the state of vascular health in convalescent COVID-19 patients, and to 109 evaluate subclinical endothelial dysfunction through the phenotyping of CECs. 110 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint factors. Among our selected convalescent COVID-19 patients (n = 30), half had at least one cardiovascular 122 risk factor including mainly hypertension, diabetes and/or hyperlipidemia. They were benchmarked to 123 healthy participants (n = 13) and non-COVID patients with matched cardiovascular risk factors (n = 20). 124

More details more demographics are included in Table 1 . 125 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint

Identification of the CEC population from individual peripheral blood mononuclear cells (PBMCs) 131 samples was carried out with high stringency using a panel of established CEC immunophenotypic markers 132 (Fig. 1a) . We first gated for the CD45 -/CD31 + population to isolate CECs along with bone marrow-derived 133 endothelial progenitor cells (EPCs) and platelets, while ruling out CD45 + leukocytes that also expressed the 134 endothelial marker CD31 (PECAM1) (Duda, Cohen et al., 2007) . This population was further subtyped 135 based on the progenitor marker, CD133, to rule out EPCs. Finally, a nucleic acid stain was used to 136 distinguish anucleate platelets from nucleated CECs defined here by a combined immunophenotypic profile 44.77, p = .001), we observed a trend of more than two folds higher mean CEC numbers in both 152 convalescent COVID-19 groups relative to healthy individuals (Fig. 1b) . Between the two convalescent 153 COVID-19 groups, patients with cardiovascular risk had higher mean CEC numbers (M = 153.75, SEM = 154 51.55) than patients without cardiovascular risk (M =116.21, SEM =28.17). These observations are 155 consistent with our hypothesis that COVID-19 patients, especially those with pre-existing cardiovascular 156 risk, may display persistent signs of vascular dysfunction even after recovery from COVID-19. 157 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020.

To ascertain the consequence of COVID-19 on endothelial dysfunction, we regrouped the convalescent 175 COVID-19 patients by their disease severity during acute infection (Fig. 1c) . We found that both 176 convalescent COVID-19 patients who recovered from moderate symptoms (p = .0284) and non-COVID-19 177 patients with cardiovascular risks (p = .0033) had significantly higher numbers of CECs than healthy 178 controls. It was surprising that convalescent COVID-19 patients from severe symptoms did not result in 179 significantly higher CEC counts, probably due to limited representations in our current sample pool. 180

Collectively, Figures 1b and 1c demonstrate the potential impact of COVID-19 and cardiovascular risk 181 factors on endothelial injury, as indicated by the number of CECs in circulation. In Figure 1d , we further 182 performed molecular profiling of CECs for endothelial activation markers. Our data revealed significant 183 difference between the mean number of SELP + CECs in convalescent COVID-19 patients with 184 cardiovascular risk and healthy individuals (p = .0291). When we analyzed their endothelial activation 185 hallmarks by disease severity (Fig. 1e) , we observed a trend that convalescent COVID-19 patients who 186 recovered from severe symptoms had the highest number of SELP+ CECs, though insignificant. As seen 187 in the spread of data in Figures 1d and 1e , large inter-individual variations in CEC numbers was expected 188 and could obscure observations of statistically significant differences in mean values. To overcome this, we 189 compared the proportion of patients with regard to the numbers of activation markers expressed by CECs 190 in each group and a chi-square goodness-of-fit test was carried out to assess if the percentages of patients 191 were similar across the groups. We found a significant relationship between the number of endothelial 192 activation markers expressed by CECs and the disease status of patients,  2 (9, N = 53) = 17.65, p = .03, 193 where convalescent COVID-19 patients compounded with cardiovascular risk had the most pronounced 194 endothelial activation hallmarks (Fig. 1f) , more than those having either a history of COVID-19 alone or 195 cardiovascular risk without COVID-19. Conversely, COVID-19 severity did not render significantly different 196 extent of endothelial activation hallmarks (Fig. 1g) . These findings demonstrate that COVID-19 may act in 197 concert with comorbidities of hypertension and diabetes to intensify risks of future vascular complications 198 due to elevated endothelial activation state. 199 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint

Multiplex microbead-based immunoassay was performed to determine the cytokine levels in COVID-201 19 patient plasma during hospital admission and after discharge. To investigate the association between 202 cytokine responses and cardiovascular risks, cytokine and chemokine levels were compared between 203 COVID-19 patients with and without cardiovascular risk during the acute and convalescent phases of 204 infection (Fig. 2a) . We found that COVID-19 patients with cardiovascular risk had lower levels patients at the early convalescent phase, particularly in those with prior cardiovascular risk, compared to 220 healthy controls (Fig. 2b) . Result from simple linear regression analysis showed that age was significantly 221 associated with the presence of cardiovascular risks in our COVID-19 patients. After adjustment for age by 222 multiple linear regression analysis, levels of RANTES at the early convalescent phase was significantly 223 associated with cardiovascular risks (Supplementary Table 1) . 224 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint

To understand whether persistent immune activation may impact on endothelial dysfunction, we 244 performed correlation analysis of cytokine levels with the aforementioned CEC attributes. Interestingly, CEC 245 attributes from convalescent patients without prior cardiovascular risk correlated significantly with a greater 246 number of cytokines than those with cardiovascular risk (Fig. 3) . This may suggest that persistent cytokine 247 production contributed primarily to endothelial injury (CEC counts) and activation hallmarks (CX3CL1+ and 248 Fig.1) . Among the positively correlated cytokines (Fig. 3) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint lymphocytes, monocytes and/or neutrophils through endothelial barrier (Sokol & Luster, 2015) . Our data 271 resonated with the findings from a study on high-cardiovascular-risk patient cohort, where RANTES 272 correlated positively with endothelial injury marker, and that increased perivascular expression of RANTES 273 was associated with vascular accumulation of T cells (Mikolajczyk, Nosalski et al., 2016) . Moreover, 274 RANTES was specifically correlated with SELP+ CEC (r = 0.5677, p = 0.0295), indicating that activated 275 platelet-derived RANTES may work in concert with endothelial SELP to mediate platelet aggregation and 276 trigger coagulation cascade. In partial correlation analyses, a majority of these CEC-cytokines correlations 277 were sustained even after accounting for age (Supplemental Table 2 Spearman rank correlation coefficients were calculated to assess associations between the level of 287 cytokines and CEC attributes in terms of mean numbers of CECs, SELP + CECs or CX3CL1 + CECs. 288

Spearman's correlation coefficient r and p values (two-tailed test) were shown in plots. 289 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint

Our ability to measure activation markers directly on CECs motivated us to better understand the receptor- severe COVID-19 patients than healthy participants (Fig. 4a) . The relationship between counter receptors 301 expression and COVID-19 disease was even more marked in Schulte-Schrepping et al. dataset with a 302 higher proportion of NK or both CD8+ and NK cells expressing all three counter receptors found in mild and 303 severe COVID-19 samples, respectively, regardless of comorbidity with cardiovascular disease 304 (Supplemental Figure 2) .As those counter receptors generally marks cytotoxic effector lymphocytes in 305 peripheral blood (Nishimura, Umehara et al., 2002), we correspondingly found that CD8+ T cells and NK 306 cells were the major cytotoxic populations expressing perforin and granzymes (Fig. 4b) , especially in 307 COVID-19 patients (Supplemental Figure 2) . Published immunophenotyping studies on convalescent 308 COVID-19 patients are still limited. Several immunophenotyping studies have reported immune exhaustion 309 phenotype and reduced antiviral cytokine production capability that were inversely correlated with COVID-310 19 severity during acute infection (summarized in Supplemental Table 3 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint protective immunity in COVID-19 convalescents (Supplemental Table 3 ). Intriguingly, a recent 318 immunophenotyping study using high-dimensional flow cytometry reported a higher proportion of activated 319 CD8+ T cells in healthy participants and to some extend recovered individuals than in COVID-19 patients 320 (Mathew, Giles et al., 2020) . Therefore, we postulate that persistent cytokine production not only activates 321 endothelial cells in convalescent COVID-19 patient but may promote direct interaction between activated 322 endothelial cells and cytotoxic effector cells. Therefore, these individuals could be susceptible to further 323 cytotoxicity-induced endothelial injury. 324 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint

The sequence of events leading to post COVID-19 complication has not been fully elucidated, but likely a 361 vicious cycle caused by vascular leakage, activation of coagulation pathway and inflammation (Teuwen, 362 Geldhof et al., 2020). Breach of endothelial barriers might have occurred early due to impairment of ACE2 363 upon SARS-CoV-2 entry, indirectly perturbing the kallikrein-bradykinin pathway, ( In our study, a number of chemokines and activated T cell-associated cytokines (IL-1, IL-2, IL-17A, and 376 RANTES) remained elevated post-infection, reflecting a broad adaptive immune response. We noted much 377 heterogeneity in the immune profiles of COVID-19 patients where one study described no substantial 378 expression of proinflammatory cytokine genes by T cells, NK cells or monocytes, to another that found 379 higher proportion of cytotoxic CD8+ T cells in severe COVID-19 individuals (summarized in Supplemental 380 Table 3 ). Similarly, we also noted differences in the expression of counter receptor and cytotoxicity 381 associated genes between the two scRNA datasets that we analyzed although both studies supported 382 higher proportion of CD8+ and NK cells expressing counter receptor and cytotoxicity associated genes in 383 COVID-19 samples. Importantly, no difference in the expression of counter receptor and cytotoxicity 384 associated genes were noted in COVID-19 patients with or without cardiovascular risk. While the nature of 385 the cardiovascular risk in Schulte-Schrepping et al dataset is not elaborated, it supports that factors other 386 than immune cytotoxicity may impact vascular health. Correspondingly, SARS-CoV-2 reactive T cells were 387 described in COVID-19 convalescents and even unexposed individuals (Grifoni, Weiskopf et al., 2020) . We 388 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Healthy participants and non-COVID-19 patients with cardiovascular risk factors were obtained from the 443 Cardiac Ageing study (Koh, Gao et al., 2018) which is a prospective observational cohort study performed 444 at the National Heart Centre Singapore. The current study sample consisted of healthy participants who 445 had no known cardiovascular disease or cerebrovascular disease or cancer. We included non-COVID-19 446 patients with cardiovascular risk factors for this comparison. All participants were examined and interviewed 447 on one study visit by trained study coordinators. Participants completed a standardized questionnaire that 448 included medical history and coronary risk factors. Sinus rhythm status was ascertained by resting 449 electrocardiogram. Clinical data were obtained on the same day as biological sample collection. 450 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint

Antecubital venous blood samples were taken from participants on the same day. After collection, the blood 453 samples were immediately placed on ice for transportation and were processed within six hours to obtain 454 buffy coat samples, which were subsequently cryopreserved. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint _infection-25.cxg/). Briefly, the uniform manifold approximation and projection (UMAP) visualization was 480 annotated using the metadata included using the "cell_type_fine" taxonomy. Due to inter-individual heterogeneities of flow cytometric and cytokine data, nonparametric tests of 495 association were preferentially used throughout this study unless otherwise stated. For flow cytometric data 496 on CEC attributes, statistical differences between groups were calculated using Kruskal-Wallis test with 497

Dunn's multiple comparison post-test. Significant p values (< 0.05) were indicated on the graphs directly. 498

To assess for differences in the frequencies of patients with CECs expressing endothelial activation 499 markers, ICAM1, SELP or CX3CL1 and the cumulative frequencies for all markers, the number of patients 500 per group were summarised in contingency tables. These were then analysed with Chi-square goodness 501 of fit test with expected values generated from the data using GraphPad Prism, version 8.3.1. 502

For the cytokine analysis, Mann Whitney U tests were used to discern the differences in cytokine levels 503 between the patients with or without cardiovascular risk factors. A multiple linear regression analysis was 504 conducted to examine the association between plasma cytokines and the presence of cardiovascular risks 505 in COVID-19 patients after adjustment for age. Heatmap and scatter plots were generated using GraphPad 506 Prism version 8. Concentrations of immune mediators were scaled between 0 and 1 for visualization in the 507 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint heatmap. Protein-protein interaction networks of the CEC associated cytokines were predicted and 508 illustrated with Search Tool for the Retrieval of Interacting Genes/Proteins database (STRING) (version 509 11.0; available at: https://string-db.org). All the interactions between cytokines were derived from high-510 throughput lab experiments and previous knowledge in curated databases at a confidence threshold of 0.4. 511

For correlative study between CEC attributes and cytokine levels, we selected non-parametric Spearman 512 correlation with no assumption regarding value distribution. Non-linear regression and Spearman rank 513 correlation coefficients were calculated to access associations between the level of serum cytokines and 514 CEC attributes for convalescent COVID-19 patients with and without cardiovascular risk factors. The level 515 of statistical significance was set at two-tailed test with p values of <0.05 to detect any significant 516 associations between specific cytokines and CEC attributes. Statistical analyses for this correlative study 517 were performed using GraphPad Prism software, version 8.3.1. To address potential age-related 518 contributions to the correlations observed between CEC and plasma cytokines in Figure 3 , non-parametric 519 partial correlation coefficients based on Spearman's rank correlations were determined for the identified 520 correlated variables while controlling for age. The R package 'ppcor' was used to compute the coefficients, 521 p values and test statistics in Supplemental Table 2 . (Kim, 2015) . 522

This study was approved by the Local Ethics Committee of the National Healthcare Group (2012/00917) 525 and Nanyang Technological University Singapore Institutional Review Board (IRB-2020-09-011). 526 527 ACKNOWLEDGEMENTS 528 We thank all clinical and nursing staff who provided care for the patients; staff in the Singapore Infectious 529

Disease Clinical Research Network and Infectious Disease Research and Training Office of the National 530

Centre for Infectious Diseases for coordinating patient recruitment. We also wish to thank Ms Siti Naqiah 531

Amrun, Ms Rhonda Sin-Ling Chee, Mr Nicholas Kim-Wah Yeo, Mr Anthony Torres-Ruesta, Drs Chek Meng 532

Poh, Cheryl Yi-Pin Lee, Guillaume Carissimo, Matthew Tay and Zi-Wei Chang from the Singapore 533

Immunology Network (SIgN), for their help in isolating PBMCs and plasma fractions from the blood of 534 COVID-19 patients. We are also grateful to Dr Danielle Anderson and her team at Duke-NUS, for their 535 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint CONFLICT OF INTEREST 564 The authors declare that they have no conflict of interest. 565 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.16.20232835 doi: medRxiv preprint

Pulmonary Vascular Endothelialitis, Thrombosis, 568 and Angiogenesis in Covid-19

Metformin improves circulating 570 endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study

Vascular function and brain-derived neurotrophic 573 factor: The functional capacity factor

Interleukin 8 and cardiovascular disease

A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic 579 absorption and an inhibitory effect on cytokines and tumor-associated microbes

IP-10 blocks vascular endothelial growth factor-induced endothelial 581 cell motility and tube formation via inhibition of calpain

Platelet-derived growth factor BB induces 583 functional vascular anastomoses in vivo

Cellular biomarkers of endothelial health: microparticles, endothelial progenitor 585 cells, and circulating endothelial cells

Synergism between vascular endothelial growth factor and placental growth factor 589 contributes to angiogenesis and plasma extravasation in pathological conditions

Inhibition of 591 natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation 592 syndrome

Lung endothelial cell 595 antigen cross-presentation to CD8(+)T cells drives malaria-associated lung injury

SARS-CoV-2 endothelial infection causes COVID-19 598 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases

Association between hospitalization for 602 pneumonia and subsequent risk of cardiovascular disease

Evaluation of inactivation methods for severe acute respiratory syndrome 604 coronavirus in noncellular blood products

Long-term Health Consequences of COVID-19

Saldiva 609 PHN, Garcia Caldini E (2020) SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem 610 inflammatory syndrome

A protocol for phenotypic detection and enumeration 612 of circulating endothelial cells and circulating progenitor cells in human blood

Circulating 614 endothelial cells as biomarker for cardiovascular diseases

Jacobson 616 D (2020) A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated 617 bradykinin storm

Metabolic 619 pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma 620 gondii: novel approach

Expression of interleukin 622 (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and 623 macrophages: implications for atherogenesis

Markers and Biomarkers of Endothelium: 625 When Something Is Rotten in the State

Circulating endothelial cells: markers of vascular dysfunction

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans 631 with COVID-19 Disease and Unexposed Individuals

Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -635 19

Extrapulmonary manifestations of COVID-19

Tissue distribution of ACE2 640 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Circulating 643 endothelial progenitor cells, vascular function, and cardiovascular risk

SARS-CoV-2 Cell Entry Depends on ACE2 646 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Angiotensin II increases expression of IP-648 10 and the renin-angiotensin system in endothelial cells

Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review

The chemokine CX3CL1 promotes trafficking of dendritic cells through 653 inflamed lymphatics

Detection of circulating endothelial cells and endothelial 655 progenitor cells by flow cytometry

ppcor: An R Package for a Fast Calculation to Semi-partial Correlation Coefficients

Dissecting Clinical and Metabolomics Associations of Left Atrial Phasic Function by Cardiac 660 Magnetic Resonance Feature Tracking

Zhang 662 Z (2020) Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Cytotoxic CD4+ T 666 lymphocytes may induce endothelial cell apoptosis in systemic sclerosis

Circulating endothelial progenitors are increased in COVID-19 669 patients and correlate with SARS-CoV-2 RNA in severe cases

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Deep immune profiling of COVID-19 patients reveals distinct immunotypes 676 with therapeutic implications

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Role of chemokine 683 RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in 684 hypertension

Circulating endothelial cells in acute ischaemic stroke

T-cell-688 mediated lysis of endothelial cells in acute coronary syndromes

The long-term impact of severe acute respiratory 690 syndrome on pulmonary function, exercise capacity and health status

Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector 693 lymphocytes that are defined by CX3CR1 expression

Circulating endothelial cells in COVID-19

Postdischarge 698 thrombosis and hemorrhage in patients with COVID-19

Thrombosis and COVID-19 pneumonia: the clot thickens! 700

Outcomes of Cardiovascular Magnetic Resonance 703 Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

Circulating endothelial cells in coronary artery disease and acute 705 coronary syndrome

Severe COVID-19 Is Marked by a Dysregulated 709

The chemokine system in innate immunity

Renal 712 histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

COVID-19: the vasculature unleashed

Cytokines and chemokines: At the crossroads of cell 716 signalling and inflammatory disease

Cytomegalovirus-induced 718 effector T cells cause endothelial cell damage

Schuepbach 720 RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19

Vascular underpinning of COVID-19

A single-cell atlas 725 of the peripheral immune response in patients with severe COVID-19

Cytokine Circuits in Cardiovascular Disease

Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment 730 of a patient in intensive care

Pathological findings of COVID-19 associated with acute 733 respiratory distress syndrome

Identification of the Ebola virus 735 glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

Long-term consequences of COVID-19: 738 research needs

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the 742 inflammatory response: an observational cohort study

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore

Viral dynamics and immune correlates of COVID-19 disease severity

Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with 752 gynecologic malignancies